Richardson D R, Neumannova V, Ponka P
Lady Davis Institute for Medical Research of the Sir Mortimer B. Davis-Jewish General Hospital, Montreal, Quebec, Canada.
Biochim Biophys Acta. 1995 May 12;1266(3):250-60. doi: 10.1016/0167-4889(95)00022-k.
The effect of congeners of nitrogen monoxide (NO) on iron (Fe) uptake from 59Fe-125I-transferrin (Tf) and release of 59Fe from prelabelled cells have been investigated in SK-MEL-28 human melanoma cells, human K562 cells and mouse MDW-4 cells. These studies have been initiated as it has been suggested that the tumoricidal effects of NO may be mediated by its acting to release Fe from cells (Hibbs et al., 1984 Biochem. Biophys. Res. Commun. 123, 716-723; Hibbs et al., 1988 Biochem. Biophys. Res. Commun. 157, 87-94). The nitrosonium ion (NO+) generator, sodium nitroprusside (SNP), decreased 59Fe uptake by melanoma cells to 57% of the control without decreasing 125I-Tf uptake after a 4-h incubation with 59Fe-125-Tf (1.25 microM). Longer incubations up to 24 h decreased 59Fe uptake and also 125I-Tf uptake. Two breakdown products of SNP, ferricyanide and cyanide, had no effect on 59Fe uptake. In addition, photolysis of the SNP solution prevented the inhibition of 59Fe uptake, suggesting that NO was the active agent. Two nitric oxide (NO.) producing agents, 3-morpholinosydnonimine (SIN), and S-nitroso-N-acetylpenicillamine (SNAP), also decreased 59Fe uptake from 59Fe-125I-Tf. Superoxide dismutase increased the efficacy of SIN, and the NO-scavenger, oxyhaemoglobin, prevented the inhibition of 59Fe uptake mediated by SNAP, again suggesting that NO was the active agent. Furthermore, dialysis studies demonstrated that none of the NO-generating agents could remove 59Fe from 59Fe-125I-Tf, suggesting that the decrease in cellular Fe uptake observed was not due to NO releasing Fe from the Fe-binding sites of Tf. Despite the ability of NO-producing agents at inhibiting 59Fe uptake by cells, they could not remove significant amounts of 59Fe from melanoma cells prelabelled with either 59Fe-citrate or 59Fe-125I-Tf. Similar data were obtained using K562 and MDW-4 cells. Interestingly, the NO+ generating agent, SNP, had no effect on [3H]thymidine uptake. However, when SNP was converted to an NO. generator by the addition of 1 mM ascorbate, its effect was similar to the NO. generator, SNAP, markedly reducing [3H]thymidine incorporation to 33% of the control value. The addition of unlabelled diferric Tf (0.625 microM) to SNAP ameliorated its inhibitory effect on cellular [3H]thymidine uptake, suggesting that the interaction of NO. with Fe was of importance in the inhibition observed. The results are discussed in the context of the cytostatic potential of NO via its binding to Fe.
在SK - MEL - 28人黑色素瘤细胞、人K562细胞和小鼠MDW - 4细胞中,研究了一氧化氮(NO)的同系物对59Fe - 125I - 转铁蛋白(Tf)摄取铁(Fe)以及预标记细胞释放59Fe的影响。开展这些研究是因为有观点认为,NO的杀肿瘤作用可能是通过促使细胞释放Fe来介导的(希布斯等人,1984年,《生物化学与生物物理学研究通讯》123卷,第716 - 723页;希布斯等人,1988年,《生物化学与生物物理学研究通讯》157卷,第87 - 94页)。亚硝鎓离子(NO +)生成剂硝普钠(SNP)与59Fe - 125 - Tf(1.25微摩尔)孵育4小时后,使黑色素瘤细胞对59Fe的摄取降至对照的57%,而不降低对125I - Tf的摄取。长达24小时的更长孵育时间降低了59Fe摄取,也降低了125I - Tf摄取。SNP的两种分解产物铁氰化物和氰化物对59Fe摄取无影响。此外,SNP溶液的光解可防止对59Fe摄取的抑制,表明NO是活性剂。两种产生一氧化氮(NO·)的试剂,3 - 吗啉代 sydnonimine(SIN)和S - 亚硝基 - N - 乙酰青霉胺(SNAP),也降低了从59Fe - 125I - Tf摄取59Fe。超氧化物歧化酶提高了SIN的效力,而NO清除剂氧合血红蛋白可防止SNAP介导的对59Fe摄取的抑制,再次表明NO是活性剂。此外,透析研究表明,没有一种NO生成剂能从59Fe - 125I - Tf中去除59Fe,这表明观察到的细胞铁摄取减少并非由于NO从Tf的铁结合位点释放铁所致。尽管产生NO的试剂能够抑制细胞对59Fe的摄取,但它们不能从预先用59Fe - 柠檬酸盐或59Fe - 125I - Tf标记的黑色素瘤细胞中去除大量的59Fe。使用K562和MDW - 4细胞也获得了类似的数据。有趣的是,NO +生成剂SNP对[3H]胸苷摄取无影响。然而,当通过添加1毫摩尔抗坏血酸将SNP转化为NO·生成剂时,其作用类似于NO·生成剂SNAP,显著将[3H]胸苷掺入量降低至对照值的33%。向SNAP中添加未标记的二价铁转铁蛋白(0.625微摩尔)可改善其对细胞[3H]胸苷摄取的抑制作用,这表明NO·与铁的相互作用在观察到的抑制中很重要。将结合铁的细胞生长抑制潜力来讨论这些结果。